Show Summary Details
Page of

Transgenics 

Transgenics
Chapter:
Transgenics
Author(s):

Sulie L. Chang

and Marley D. Kass

DOI:
10.1093/med/9780195399349.003.0028
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 June 2019

The development and optimization of animal models for neuroAIDS research is a challenging but necessary step toward delineating and effectively treating the central and peripheral neuropathologies that emerge with long-term HIV infection in humans. Because large-animal models, such as non-human primate models, are expensive and of limited availability, developing small-animal models of HIV disease, including with mice and rats, is important. Although certain aspects of HIV disease are modeled well by murine leukemia viruses and with the xenotransplantation of severe combined immunodeficient mice, there are situations where transgenic (Tg) models are uniquely valuable. Tg mice and rats expressing either the full HIV-1 genome or specific HIV-1 genes can mimic neuropathological abnormalities and cognitive, motor, and behavioral impairments observed in human HIV-1 disease. This chapter provides a detailed overview of transgenic murine models for HIV infection in humans.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.